Mabsilico
AI-based antibody candidate design for biotech and pharma companies, with candidates delivered in 21 days
Highlights
- New on EvolcAdded 2026-11-02
About Mabsilico
MAbSilico designs therapeutic antibody candidates using computational in silico methods, including AI-based docking and affinity prediction against chosen epitopes. Its design process also evaluates off-target and inter-species reactivity, and sequence liabilities such as post-translational modifications and aggregation motifs. The company also offers MAbFactory, a software platform for antibody characterization available to its partners.
Customers are biotech companies, startups and pharmaceutical companies; the website states 55 customers worldwide and 16 partnering programs for antibody design ongoing. Recent partnerships include a developability and manufacturability assessment service with Sartorius and a collaboration with YntoAb in South Korea.
MAbSilico was founded in 2017 and is headquartered in Tours, France. It was founded by four scientists, and its advisory board includes a professor of immunology at Tours Université. The company has received support from Bpifrance.
Product: AI-based therapeutic antibody design service delivering lead candidates in 21 days, plus the MAbFactory software for antibody characterization.
Jobs at Mabsilico
Leadership
- Vincent Puard · CEOSource: company website
- Anne Poupon · CTOSource: company website
More biotech & pharma companies
Metafora Biosystems
Develops single-cell metabolic testing and analysis for diagnostic and cell therapy applicationsNew on EvolcMexbrain
Develops dialysis-based medical devices to remove excess metals from the blood of patients with metal-related conditionsNew on EvolcMicrophyt
Microalgae-based ingredients for health, nutrition, well-being and beauty businessesNew on EvolcMimabs
Preclinical antibody and ADC discovery and development services for biotech, pharmaceutical and academic research partnersNew on EvolcMycea
Develops fungal-extract crop protection candidates for agricultural and biocontrol partnersNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4Medium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinitialization/configuration expression
- Integration code on pageinitialization/configuration expression
- Integration code on pageinitialization/configuration expression
- Google Tag ManagerMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- WebflowHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- AWSHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- AzureMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Privacy & consent
- AxeptioMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.